Long-term results of Birmingham hip resurfacing arthroplasty in Asian patients

Several reports have shown good long-term results with the Birmingham hip resurfacing (BHR) arthroplasty, but little is known about the results in Asian countries where there is a high prevalence of osteonecrosis and developmental dysplasia of the hip, and many females with small femoral head sizes. Therefore, we retrospectively evaluated the long-term clinical results of the BHR in 112 Japanese patients (53 males and 59 females—130 hips) with an average age of 52 years. Implant survivorship was analyzed using the Kaplan–Meier method with the endpoint being revision for any reason. Factors such as sex, femoral component size, and type of hip disease were analyzed as predictors of implant survivorship. With a median follow-up of 12 years, six cases were revised (two for femoral component aseptic loosening, two for infection, one for cup aseptic loosening, and one for femoral neck fracture), and the overall survival rate was 96.5% (95% CI 90.9–98.7) at 10 years and 93.6% (95% CI 83.4–97.7) at 15 years. When septic revisions were excluded, the implant survival rate was 98.2% (95% CI 92.9–99.6) at 10 years and 95.3% (95% CI 83.9–98.7) at 15 years. Sex, femoral component size, and type of hip disease were not predictors of implant survivorship. In conclusion, good clinical results were obtained with the BHR at 10- and 15-year follow-up in Japanese patients who have different stature and types of hip diseases as compared with patients in Western countries.